Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma

Fig. 3

Low level of miR-625-3p decreased growth and promoted cisplatin sensitivity. A Growth of OVCAR3 cells decreased miR-625-3p without cisplatin. B-D Growth of OVCAR3 cells decreased miR-625-3p in presence of different doses of cisplatin (1, 2 and 4μM). E Growth of OVCAR4 cells decreased miR-625-3p without cisplatin. F-H Growth of OVCAR4 cells decreased miR-625-3p in presence of different doses of cisplatin (1, 2 and 4μM)

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us